Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Paraproteinemias × daratumumab × Clear all

Sponsor

Conditions

Multiple Myeloma 35 Leukemia, Myeloid, Acute 4 Recurrence 3 Waldenstrom Macroglobulinemia 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hypergammaglobulinemia 1 Hodgkin Disease 1

Interventions

Bortezomib 3 fludarabine 2 Tacrolimus 2 Cyclophosphamide 2 ofatumumab 1 fludarabine phosphate 1 birtamimab 1 Zoledronic Acid 1 Whole-Body Irradiation 1 Vorinostat 1 Thalidomide 1 Stem Cell Transplantation 1 Plasma Exchange 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 KW-2478 1 Hsp90 inhibitor KU757 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Denosumab 1 Cisplatin 1 Calcium Dobesilate 1 Busulfan 1 Alemtuzumab 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡